Flu-like sickness is a wide-ranging category including a fever of at least 100°F (37.8°C) and a cough or sore throat.3 In 2018, it was estimated that over the previous 5 years, the average number of symptomatic cases in the US was 33 million/year.4
Flu-like sickness is frequent and can be severe. Even when excluding hospitalizations, it poses a substantial burden on families, societies, and economies due to the costs associated with doctor consultations, medicine prescriptions, and loss of productivity.5
These data suggest that if everyone living in America consumed probiotics, there would be a significant cost saving associated with flu-like sickness. Therefore, supplementing with probiotics may not only be beneficial to health,9, 10, 11, 12 but also may reduce societal and the economic burden.1
Read more about probiotics and boosting immune health
LGG® and BB-12® are registered trademarks of Chr. Hansen A/S.
The article is provided for informational purposes regarding probiotics and is not meant to suggest that any substance referenced in the article is intended to diagnose, cure, mitigate, treat, or prevent any disease.
Lactobacillus rhamnosus, LGG® is the world’s most documented probiotic strain. The LGG® strain has proven benefits across all ages and numerous health areas, including gastrointestinal, immune and oral health.
LGG® is a registered trademark of Chr. Hansen A/S
The probiotic strain Bifidobacterium, BB-12® is the world’s most documented probiotic bifidobacterium. It has been extensively studied and has been associated with improved outcomes across various health areas.
BB-12® is a trademark of Chr. Hansen A/S